This white paper demonstrated capture of a biotinylated oligonucleotide using a streptavidin modified surface. Subsequently, kinetic measurements were performed demonstrating that the oligonucleotide can bind DNA-binding proteins. The streptavidin modification highlights the platform as a cost-effective and sensitive option for biomolecular interactions, benefiting the life science research community.
We are thrilled to announce an exciting webinar by Senior Scientist Arnoud Marquart on label-free biosensing, a revolutionary approach that enhances kinetics and quantitative measurements for a wide range of biomolecules, from small molecules to antibodies.
In this webinar, we’ll delve into the techniques, applications, and breakthroughs enabled by label-free biosensing and the inQuiQ®, an multiplex label-free biosensing instrument based on integrated photonics.
Agenda of the webinar:
Who should attend?
Scientists, researchers, and innovators looking to explore the potential of label-free biosensing in their work. Feel free to share this invitation with colleagues who might benefit.
When and where?
The first webinar will be held live and online on Tuesday 28 of January, 16:00 CET.
Subscribe now: https://meet.zoho.eu/U0bd8jScmy
June 2024, Rotterdam- Delta Life Science, a leader in label-free, multiplexed biosensing, brings inQuiQ® to market.
Powered by our Nanophotonic Evanescent field Sensing (NES) technology, the inQuiQ® allows scientists to conduct highly sensitive, multiplexed analyses with sample volumes from 10 µl to 2 ml on a reusable photonic sensor. Taking up only an A3 paper-size space in your laboratory, the compact inQuiQ® gives you real-time data with improved 16-plex measurements in serum, plasma, and supernatant.
“The maximum sample volume that can be drawn from mice is about 100 microliters. For our research, we need to maximize what we can measure from these small samples. The highly multiplexed detection technology which is able to measure many different biomolecular interactions simultaneously using minimal sample volumes, is therefore essential for us.” – Prof. Dr. F. Grosveld, Erasmus MC / Harbour Antibodies
From drug development to food safety, studying the interaction of any combination of biomolecules, the applications of the inQuiQ® instrument are designed for customizable assays regardless of the life sciences field you are in.
What’s in store for 2025?
If your need for throughput has increased, Delta Life Science will launch its second instrument, the inQuiQ® 768 in 2025. The add-on to the base model integrates an autosampler, enabling the analysis of two well plates in one run. Additionally, a GxP version will be available, compliant with 21 CFR pt. 11 regulations.
Discover how inQuiQ® can enhance your analysis.
About Delta Life Science
Delta Life Science, headquartered in Rotterdam, The Netherlands, is committed to revolutionizing biosensing technology by making label-free, multiplexed biosensors and instruments accessible to all. The company’s innovative approach to biosensing, using photonic integrated circuits, reduces the complexity and cost of traditional lab methods. By providing a rapid, sensitive, low-cost solution, Delta Life Science aims to empower researchers and industry professionals to make groundbreaking advancements in Life Sciences.
Press Contact
Bart Stenneken, Delta Life Science
mobile +31615463508
email bart.stenneken@deltalifescience.nl
This white paper demonstrated capture of a biotinylated oligonucleotide using a streptavidin modified surface. Subsequently, kinetic measurements were performed demonstrating that the oligonucleotide can bind DNA-binding proteins. The streptavidin modification highlights the platform as a cost-effective and sensitive option for biomolecular interactions, benefiting the life science research community.
The inQuiQ™ instrument uses unique optical technology with ring-resonators for precise molecular binding measurements, facilitating real-time, label-free analysis of biomolecular interactions. This white paper demonstrates the instrument’s effectiveness in high-throughput analysis of the association of biomolecules. This highlights the instrument as a cost-effective and sensitive option for rapid quantitation, making advanced research on biomolecular interactions more accessible to the life science research community.